Elbion Overview

  • Founded
  • 2002
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2
  • Investments
  • 1

Elbion General Information

Description

Provider of pharmaceutical research and development services. The company operates as a specialty pharmaceutical company focused on the development and commercialization of therapeutics for neurological diseases and immunological disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Acquirer
Biotie Therapies
Primary Office
  • Meissner Straße 191
  • 01445 Radebeul
  • Germany
+49 0351 00000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Elbion Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Elbion‘s full profile, request access.

Request a free trial

Elbion Executive Team (1)

Name Title Board Seat Contact Info
Bernd Kastler Chief Executive Officer
To view Elbion’s complete executive team members history, request access »

Elbion Board Members (1)

Name Representing Role Since
000 0000000 Self Chairman 000 0000
To view Elbion’s complete board members history, request access »

Elbion Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Elbion‘s full profile, request access.

Request a free trial

Elbion Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0 000 0000000000 12-Aug-2006 000000000000000000 Biotechnology
To view Elbion’s complete acquisitions history, request access »